138 related articles for article (PubMed ID: 14702965)
1. Nerve agent toxicology.
Wood SP
JEMS; 2003 Dec; 28(12):16; author reply 16. PubMed ID: 14702965
[No Abstract] [Full Text] [Related]
2. Atropine use in children after nerve gas exposure.
Lynch M
J Pediatr Nurs; 2005 Dec; 20(6):477-84. PubMed ID: 16298290
[No Abstract] [Full Text] [Related]
3. [Antidose therapy for organophosphate poisoning].
Iseki K
Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
[No Abstract] [Full Text] [Related]
4. What target pralidoxime concentration?
Dawson A; Buckley N; Whyte I
J Toxicol Clin Toxicol; 1997; 35(2):227-30. PubMed ID: 9120899
[No Abstract] [Full Text] [Related]
5. Treatment for nerve-poisoning agents.
FDA Consum; 2006; 40(6):6. PubMed ID: 17333555
[No Abstract] [Full Text] [Related]
6. Nerve agents: implications for anesthesia providers.
Hrobak PK
AANA J; 2008 Apr; 76(2):95-7. PubMed ID: 18478812
[TBL] [Abstract][Full Text] [Related]
7. Accidental injection of a U.S. Air Force aviator by a pralidoxime chloride auto-injector: a case report.
Yamane GK
Aviat Space Environ Med; 1999 Nov; 70(11):1110-2. PubMed ID: 10608609
[TBL] [Abstract][Full Text] [Related]
8. Antidotes for nerve agent poisoning: should we differentiate children from adults?
Baker MD
Curr Opin Pediatr; 2007 Apr; 19(2):211-5. PubMed ID: 17496768
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning.
Schexnayder S; James LP; Kearns GL; Farrar HC
J Toxicol Clin Toxicol; 1998; 36(6):549-55. PubMed ID: 9776957
[TBL] [Abstract][Full Text] [Related]
10. Treatment of sarin exposure.
Schier JG; Hoffman RS
JAMA; 2004 Jan; 291(2):182; author reply 182-3. PubMed ID: 14722139
[No Abstract] [Full Text] [Related]
11. Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.
Murray DB; Eddleston M; Thomas S; Jefferson RD; Thompson A; Dunn M; Vidler DS; Clutton RE; Blain PG
Ann Emerg Med; 2012 Oct; 60(4):424-30. PubMed ID: 22738685
[TBL] [Abstract][Full Text] [Related]
12. Nerve agent attack: a dangerous threat to emergency responders & the public.
Suprun SC
JEMS; 2003 Oct; 28(10):60-71. PubMed ID: 14583704
[No Abstract] [Full Text] [Related]
13. Prevention and treatment of nerve gas poisoning.
Med Lett Drugs Ther; 1990 Nov; 32(831):103-5. PubMed ID: 2233511
[No Abstract] [Full Text] [Related]
14. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning.
DeLorenzo RA
JEMS; 2001 Jun; 26(6):48-57. PubMed ID: 11409202
[No Abstract] [Full Text] [Related]
15. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
Worek F; Szinicz L; Eyer P; Thiermann H
Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
[TBL] [Abstract][Full Text] [Related]
16. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
17. Hazardous-materials antidotes.
Vaughan WJ
Emerg Med Serv; 2004 Apr; 33(4):71-3. PubMed ID: 15131910
[No Abstract] [Full Text] [Related]
18. Case of the month. Suspicion--an important EMS asset.
Werfel P
JEMS; 2001 Dec; 26(12):20. PubMed ID: 11771370
[No Abstract] [Full Text] [Related]
19. The history of pyridinium oximes as nerve gas antidotes: the British contribution.
Petroianu GA
Pharmazie; 2013 Nov; 68(11):916-8. PubMed ID: 24380243
[TBL] [Abstract][Full Text] [Related]
20. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.
Sakurada K; Matsubara K; Shimizu K; Shiono H; Seto Y; Tsuge K; Yoshino M; Sakai I; Mukoyama H; Takatori T
Neurochem Res; 2003 Sep; 28(9):1401-7. PubMed ID: 12938863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
